Correlation Between Fulcrum Therapeutics and Nextnav Acquisition

Can any of the company-specific risk be diversified away by investing in both Fulcrum Therapeutics and Nextnav Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fulcrum Therapeutics and Nextnav Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fulcrum Therapeutics and Nextnav Acquisition Corp, you can compare the effects of market volatilities on Fulcrum Therapeutics and Nextnav Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fulcrum Therapeutics with a short position of Nextnav Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fulcrum Therapeutics and Nextnav Acquisition.

Diversification Opportunities for Fulcrum Therapeutics and Nextnav Acquisition

0.43

Correlation Coefficient

Fulcrum Therapeutics  Nextnav Acquisition

Very weak diversification

The 3 months correlation between Fulcrum and Nextnav is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Fulcrum Therapeutics and Nextnav Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextnav Acquisition Corp and Fulcrum Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fulcrum Therapeutics are associated (or correlated) with Nextnav Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextnav Acquisition Corp has no effect on the direction of Fulcrum Therapeutics i.e., Fulcrum Therapeutics and Nextnav Acquisition go up and down completely randomly.

Pair Corralation between Fulcrum Therapeutics and Nextnav Acquisition

Given the investment horizon of 90 days Fulcrum Therapeutics is expected to under-perform the Nextnav Acquisition. In addition to that, Fulcrum Therapeutics is 1.15 times more volatile than Nextnav Acquisition Corp. It trades about 0.0 of its total potential returns per unit of risk. Nextnav Acquisition Corp is currently generating about 0.13 per unit of volatility. If you would invest  440.00  in Nextnav Acquisition Corp on October 7, 2024 and sell it today you would earn a total of  1,171  from holding Nextnav Acquisition Corp or generate 266.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Fulcrum Therapeutics  vs.  Nextnav Acquisition Corp

Fulcrum Therapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Fulcrum Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain essential indicators, Fulcrum Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Nextnav Acquisition Corp

Risk-Adjusted Performance

24 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Nextnav Acquisition Corp are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Nextnav Acquisition displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Fulcrum Therapeutics and Nextnav Acquisition

The main advantage of trading using opposite Fulcrum Therapeutics and Nextnav Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fulcrum Therapeutics position performs unexpectedly, Nextnav Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextnav Acquisition will offset losses from the drop in Nextnav Acquisition's long position.

The idea behind Fulcrum Therapeutics and Nextnav Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.